The reason for the recall is related to potential increased recovery of patient results (approximately 15-20%) while using the online TDM Gentamicin assay on Roche cobas c 311, c501/c502, c701/c702 or modular p platforms in combination with Preciset TDM I of specific lots. This issue does not affect the Gentamicin reagent used on the COBAS INTEGRA systems.